CARA

See Why Cara Therapeutics (CARA) Stock Is Moving Higher On Tuesday

Cara Therapeutics Shares Increase Over 20% Pre-Market: Why It Happened

Vifor Pharma and Cara Therapeutics announce U.S. FDA approval of KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients

Cara Therapeutics and Vifor Pharma announce U.S. FDA approval of KORSUVA™ (difelikefalin) injection for the treatment of moderate-to-severe pruritus in hemodialysis patients

Is the Options Market Predicting a Spike in Cara Therapeutics (CARA) Stock?

Cara Therapeutics: 200% Upside Possible With FDA Approval